Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Tiandakang Pharmaceutical Co., Ltd. is a pharmaceutical enterprise based in Tianjin, China, that focuses on the development and production of chemical drugs and traditional Chinese medicines (TCM). Founded in 1992 and closely affiliated with Tianjin University, the company has established a diverse portfolio targeting cardiovascular, respiratory, and anti-infective therapeutic areas. Key products include Compound Salvia Miltiorrhiza Tablets for heart health and various sustained-release formulations for chronic conditions like hypertension. The company operates under strict GMP standards and serves as a significant player in the regional healthcare market. By leveraging its academic roots, Tiandakang bridges the gap between laboratory research and industrial-scale pharmaceutical production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tian Dakang.